Kaliuzhnyĭ L V, Kozlov A Iu, Litvinova S V, Shul'govskiĭ V V
Vestn Ross Akad Med Nauk. 1994(10):19-24.
The paper reviews the data available in the literature and the authors own data demonstrating the differences in the levels of endogenous opioids and in the effects of enkephalinase inhibitor and naloxone in morphine-responsive and morphine-resistant and -tolerant animals. In the morphine-tolerant animals, a single administration of enkephalinase inhibitor or some doses of naloxone was found to produce an analgesic effect leading to a short-term analgesic effect of morphine. Chronic administration of naloxone causing a gradual decrease in and subsequent cessation of its analgesic effect leads to recovery of morphine's analgesic effect in the drug-resistant and -tolerant animals. It is suggested that the morphine-resistant animals have a congenital high activity of enkephalinase, while the drug-tolerant ones have its acquired high activity. Naloxone in certain doses with the high activity of enkephalinase act as its inhibitor, but in high doses acts as its opioid antagonist.
本文回顾了文献中的现有数据以及作者自己的数据,这些数据表明内源性阿片类物质水平以及脑啡肽酶抑制剂和纳洛酮在吗啡反应性、吗啡耐药性和耐受性动物中的作用存在差异。在吗啡耐受的动物中,发现单次给予脑啡肽酶抑制剂或某些剂量的纳洛酮会产生镇痛作用,从而导致吗啡产生短期镇痛效果。长期给予纳洛酮会导致其镇痛作用逐渐减弱并随后停止,从而使耐药和耐受动物恢复吗啡的镇痛作用。有人认为,吗啡耐药动物的脑啡肽酶先天性活性较高,而药物耐受动物的脑啡肽酶活性是后天获得的。在脑啡肽酶活性较高时,某些剂量的纳洛酮可作为其抑制剂,但高剂量时则作为阿片类拮抗剂。